Latest news
Rhythm Pharmaceuticals (RYTM) Reports Promising RM 718 Data, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:36:26 GMTRevolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:02:00 GMTRhythm's drug shows promise for brain tumor-related weight condition in small study - ReutersReuters · Tue, 04 Aug 2026 14:06:46 GMTRhythm Pharmaceuticals Reports Preliminary Phase 2 RM-718 Data in Acquired Hypothalamic Obesity; Hosts Q2 2026 Conference Call - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:00:00 GMT